FOLINEX Trademark

Trademark Overview

On Thursday, December 5, 2019, a trademark application was filed for FOLINEX with the United States Patent and Trademark Office. The USPTO has given the FOLINEX trademark a serial number of 88717145. The federal status of this trademark filing is REGISTERED as of Tuesday, August 9, 2022. This trademark is owned by Vivera Pharmaceuticals, Inc.. The FOLINEX trademark is filed in the Pharmaceutical Products category with the following description:

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of prescription dosage capsules that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral capsules for the continuous release of a wide variety of therapeutic agents; all of the foregoing excluding pharmaceutical preparations and substances for the treatment of the central nervous system, sleep disorders, and neurological diseases or disorders
folinex

General Information

Serial Number88717145
Word MarkFOLINEX
Filing DateThursday, December 5, 2019
Status700 - REGISTERED
Status DateTuesday, August 9, 2022
Registration Number6815540
Registration DateTuesday, August 9, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 14, 2020

Trademark Statements

Goods and ServicesDrug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of prescription dosage capsules that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral capsules for the continuous release of a wide variety of therapeutic agents; all of the foregoing excluding pharmaceutical preparations and substances for the treatment of the central nervous system, sleep disorders, and neurological diseases or disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 11, 2019
Primary Code005
First Use Anywhere DateThursday, December 5, 2019
First Use In Commerce DateThursday, March 17, 2022

Trademark Owner History

Party NameVivera Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNewport Beach, CA 92660
Party NameVivera Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewport Beach, CA 92660
Party NameVivera Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewport Beach, CA 92660

Trademark Events

Event DateEvent Description
Thursday, March 7, 2024WITHDRAWAL OF ATTORNEY GRANTED
Thursday, March 7, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Tuesday, August 9, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 9, 2022REGISTERED-PRINCIPAL REGISTER
Friday, July 8, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, July 7, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, June 27, 2022STATEMENT OF USE PROCESSING COMPLETE
Tuesday, June 7, 2022USE AMENDMENT FILED
Monday, June 27, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 7, 2022TEAS STATEMENT OF USE RECEIVED
Saturday, December 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 9, 2021SOU EXTENSION 3 GRANTED
Thursday, December 9, 2021SOU EXTENSION 3 FILED
Thursday, December 9, 2021SOU TEAS EXTENSION RECEIVED
Friday, June 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 9, 2021SOU EXTENSION 2 GRANTED
Wednesday, June 9, 2021SOU EXTENSION 2 FILED
Wednesday, June 9, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, December 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 4, 2020SOU EXTENSION 1 GRANTED
Friday, December 4, 2020SOU EXTENSION 1 FILED
Friday, December 4, 2020SOU TEAS EXTENSION RECEIVED
Monday, October 12, 2020WITHDRAWAL OF ATTORNEY GRANTED
Monday, October 12, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Thursday, October 8, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 8, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 8, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 9, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 14, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 14, 2020PUBLISHED FOR OPPOSITION
Wednesday, March 25, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 9, 2020ASSIGNED TO LIE
Friday, February 28, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 6, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 5, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 5, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, February 1, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, February 1, 2020NON-FINAL ACTION E-MAILED
Saturday, February 1, 2020NON-FINAL ACTION WRITTEN
Saturday, February 1, 2020ASSIGNED TO EXAMINER
Wednesday, December 11, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 9, 2019NEW APPLICATION ENTERED

Related Keywords

folinex delivery agents drug wide capsules release variety form preparations pharmaceutical